key: cord-1008826-zl81g07n
authors: Morris, Gerwyn; Bortolasci, Chiara C.; Puri, Basant K.; Olive, Lisa; Marx, Wolfgang; O'Neil, Adrienne; Athan, Eugene; Carvalho, Andre; Maes, Michael; Walder, Ken; Berk, Michael
title: The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach
date: 2020-07-31
journal: Life Sci
DOI: 10.1016/j.lfs.2020.118166
sha: b5bd825b7ec53838d6398fb3f6946e0cfc65253d
doc_id: 1008826
cord_uid: zl81g07n

In this paper, a model is proposed of the pathophysiological processes of COVID-19 starting from the infection of human type II alveolar epithelial cells (pneumocytes) by SARS-CoV-2 and culminating in the development of ARDS. The innate immune response to infection of type II alveolar epithelial cells leads both to their death by apoptosis and pyroptosis and to alveolar macrophage activation. Activated macrophages secrete proinflammatory cytokines and chemokines and tend to polarise into the inflammatory M1 phenotype. These changes are associated with activation of vascular endothelial cells and thence the recruitment of highly toxic neutrophils and inflammatory activated platelets into the alveolar space. Activated vascular endothelial cells become a source of proinflammatory cytokines and reactive oxygen species (ROS) and contribute to the development of coagulopathy, systemic sepsis, a cytokine storm and ARDS. Pulmonary activated platelets are also an important source of proinflammatory cytokines and ROS, as well as exacerbating pulmonary neutrophil-mediated inflammatory responses and contributing to systemic sepsis by binding to neutrophils to form platelet-neutrophil complexes (PNCs). PNC formation increases neutrophil recruitment, activation priming and extraversion of these immune cells into inflamed pulmonary tissue, thereby contributing to ARDS. Sequestered PNCs cause the development of a procoagulant and proinflammatory environment. The contribution to ARDS of increased extracellular histone levels, circulating mitochondrial DNA, the chromatin protein HMGB1, decreased neutrophil apoptosis, impaired macrophage efferocytosis, the cytokine storm, the toll-like receptor radical cycle, pyroptosis, necroinflammation, lymphopenia and a high Th17 to regulatory T lymphocyte ratio are detailed.

The Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) is a zoonotic βcoronavirus that is closely related to SARS-CoV, which also entered the human population from an animal host (de Wit et al. , 2016 . SARS-CoV-2 is the cause of COVID-19. This is an illness that appears to lead to mild symptoms in the majority of people and indeed, many infected individuals remain asymptomatic throughout the course of the infection . However, the illness often develops to severe pneumonia and acute respiratory distress syndrome (ARDS), leading to considerable morbidity and mortality. Case fatality rates (CFR) may be as high as 6.6% , Wang et al. , 2020e, Zhu et al. , 2020 . While the CFR attributed to SARS-CoV induced SARS was considerably higher and according to the World Health Organisation (WHO) may have J o u r n a l P r e -p r o o f 6 exceeded 15% (Donnelly et al. , 2003) . However, the absolute number of people killed by/with SARS-CoV-2, to date, is greater than both SARS and middle east respiratory syndrome (MERS) combined (Mahase, 2020) . This is largely owing to a much higher rate of transmission, different tissue tropism and due to significant changes in its genome and protein structure compared to the other viruses (reviewed by (Petrosillo et al. , 2020) ).

SARS-CoV-2 enters permissive cells as a result of S spike protein high affinity engagement with angiotensin converting enzyme (ACE)-2 receptors and subsequent cleavage by the adjacent protease TMPRSS2 in a similar manner to SARS-CoV (Vaduganathan et al. , 2020 , Verdecchia et al. , 2020 . However, SARS-CoV-2 initially enters and replicates in epithelial cells of the upper respiratory tract (Sungnak et al. , 2020 , Zou et al. , 2020 . This phenomenon is not observed in SARS-CoV to any significant extent (Mason, 2020, Wu and McGoogan, 2020) . This process likely explains the relatively high viral load in the upper respiratory tract , increased levels of viral shedding (Zou et al., 2020) and significantly higher transmissibility (Liu et al. , 2020d) .

This difference in tropism may be explained in part by an increased affinity towards ACE-2 receptors, which appears to be between 10 and twenty times higher than that displayed by SARS-CoV (Tai et al. , 2020 , Wrapp et al. , 2020 . This allows SARS-CoV-2 to readily replicate in the upper respiratory tract despite a relative paucity of ACE-2 bearing cells in that region (Bertram et al. , 2012 , Hamming et al. , 2004 .

In addition, the SARS-CoV-2 spike protein contains a Furin cleavage site in the spike protein that does not exist in SARS-CoV (Coutard et al. , 2020 , Ou et al. , 2020 , Walls et al. , 2020 , allowing cleavage by cellular polyprotein convertases, such as furin and capthesin and potentially enhancing the efficiency of entry by endocytosis (Hoffmann et al. , 2020 , Sungnak et al., 2020 . In this context, it is noteworthy that the Furin cleavage site is also J o u r n a l P r e -p r o o f 7 seen in spike proteins of pandemic strains of influenza, including the strain responsible for the so called "Spanish flu" of the early 20th century (Coutard et al., 2020 , Kido et al. , 2012 .

The benefit to those viruses in possession of the cleavage site is increased tropism, it is conceivable that SARS-CoV-2 might be able to infect and replicate in otherwise nonpermissive cells in the upper respiratory tract. There is also some evidence to suggest that cathepsin may be an alternative spike cleavage protease in cells expressing ACE-2 receptors but lacking Transmembrane protease, serine 2 (TMPRSS2 ) which normally plays an indispensable role in the cleavage of the spike protein thereby enabling the fusion of the viral and host membrane (Hoffmann et al., 2020) .

While changes in tissue tropism and increased cell internalisation play a role in the high transmissibility of the virus, another factor is the initially muted immune response following infection (O'Brien et al. , 2020) . Mechanistically, this is due to significant changes in the structure of the orf3a protein in SARS-CoV-2 compared to SARS-CoV, which allows a greater capacity to inhibit the production of interferons I, II and III (Blanco-Melo et al. , 2020 , Konno et al. , 2020 , Sallard et al. , 2020 . A schematic of the proposed pathways involved is presented in Figure 1 . The inhibition of the interferon response in infected cells in the upper respiratory tract allows for relatively unhindered replication of the virus, which in combination, makes an additional contribution to a high viral load in the upper respiratory tract (URT). Importantly, these factors also explain the high levels of the virus in the URT and goes some way to explaining the high transmission rates by pre and asymptomatic people which according to some studies may account for as many as half of all transmissions) (Liu et al., 2020e) . This may further explain why the spread of this virus has been so difficult to control , Rothe et al. , 2020 , Zou et al., 2020 . J o u r n a l P r e -p r o o f 8 Evidence accrued from the initial epidemic of COVID-19 in the Wuhan province of China suggests that approximately 20% of patients infected with COVID-19 develop severe disease that require hospitalisation. In addition, 20% of admitted patients develop pneumonia and ARDS thereafter, requiring protracted ventilation . In almost 50% of cases death occurred from respiratory failure .

The presence of invading RNA viruses is detected by a family of Toll like receptors (TLRs) RIG like receptors and NOD-like receptors. From the perspective of coronavirus recognition, the important TLRs are TLR-7 and 3 which recognise single stranded RN and the dimers of positive and negative sense RNA formed during coronavirus replication. TLR 3 and 7 are located in late endosomes which maximises viral interaction while denying the pathogen's access to the cytoplasm and nucleus. Activation of these pattern recognition receptors results in the transcription of NF-κB and INF5 leading to the production of PICs inducible nitric oxide prostaglandins and a large number of chemokines. The presence of coronavirus RNA is also recognised by the retinoic acid-inducible gene I (RIG-)-like receptors RIG-1 and MDA5 which are located in the cytoplasm. The activation of either PPR results in the assembly of a protein complex known as MAVS which acts as a signal relay to trigger the J o u r n a l P r e -p r o o f activation of INF3 and INF-7 leading to the production of type 1 II and III interferons. There is also evidence to suggest that coronavirus activate nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs) leading to the assembly of the NLRP3 inflammasome and the resultant production of IL-18 and IL-1.There is evidence that SARSCoV-2 inhibits interferon via the production of the non-structural proteins ORF3a and nsp-3 leading to a muted immune response and enhanced viral replication.

COVID-19 ARDS is typified by the presence of diffuse alveolar damage, fibrin-rich hyaline membranes, increased epithelial and endothelial cell permeability, fluid leakage into the pulmonary interstitium, gross disruption of gas exchange, hypoxia and respiratory failure (Carsana et al. , 2020 , Fox et al. , 2020 , Tian et al. , 2020 reviewed in (Ranucci et al. , 2020) . These features are characteristic of ARDS secondary to sepsis, viral infections or many other triggers and in this respect, COVID-19 ARDS is unremarkable (Gonzales et al. , 2015) .

However, in another respect COVID-19 ARDS appears to be distinct from the ARDS associated with other respiratory viruses (e.g. H1N1 influenza Virus) due to evidence of hypercoagulation and an exhausted fibrinolytic system (Gattinoni et al. , 2020a , Gattinoni et al. , 2020b , Ranucci et al., 2020 , Tang et al. , 2020 . The importance of hypercoagulation in the pathogenesis of severe COVID-19 is further emphasised by an analysis which revealed that 70% of fatal cases satisfied a diagnosis for disseminated intravascular coagulation (DIC), while that was true in only 1% of survivors .

Several research teams have reported the presence of gross immune dysregulation in the lungs of patients with severe disease. For example, there is extensive evidence of activated alveolar macrophages (Carsana et al., 2020 , Liao et al. , 2020 , Mason, 2020 ) and a depletion in the absolute numbers of these immune cells due to excessive levels of pyroptosis (Liao et al., 2020 , Salomé and Magen, 2020 , Yang, 2020 . Excessive infiltration of activated neutrophils into alveoli and lung interstitial tissue is another J o u r n a l P r e -p r o o f 10 common finding in severe COVID-19 (Fox et al., 2020 , Yao et al. , 2020b review (Qin et al. , 2020) . Importantly, evidence suggests that these neutrophils are a source of highly toxic neutrophil extracellular traps (NETs) (Fox et al., 2020 , Zuo et al. , 2020 . Influx of interleukin (IL)-1 and tumor necrosis factor (TNF) secreting bone marrow derived monocytes is also a finding in such individuals (Wen et al. , 2020) . Interestingly, these monocytes also secrete lactate dehydrogenase indicating that these immune cells are also undergoing cell death via pyroptosis (Wen et al., 2020) . The presence of excessive levels of inflammation in patients with COVID-19 ARDS is further reinforced by evidence of hypercytokinemia (Liao et al., 2020 , Mehta et al. , 2020 , Zhang et al. , 2020b .

There is also an accumulating body of evidence suggesting excessive systemic immune activation and inflammation in patients suffering from COVID-19, with increased levels of TNF-alpha, IL-1 beta, IL-6, IL-10, monocyte chemoattractant protein-1 (MCP-1) and C-X-C motif chemokine 10 (CXCL10), being commonly reported in patients with severe symptoms and pneumonia (Liao et al., 2020 , Qin et al., 2020 , Shi et al. , 2020b , Zhang et al. , 2020c . Furthermore, the extent of immune activation and inflammation increases with severity of disease and is some cases ten-fold higher in critically ill patients compared to those with mild disease (Chen et al. , 2020b) .

The importance of peripheral immune activation in the pathogenesis of severe COVID-19 is further emphasised by replicated data demonstrating that the plasma neutrophil: lymphocyte ratio is predictive of both disease severity and mortality (Liu et al. , 2020c) . This concept is further supported by data suggesting that levels of IL-6 in the bloodstream correlate with symptom severity and morbidity, as well as being predictive of mortality (Chen et al., 2020b , Guo et al. , 2020 , Mehta et al., 2020 . In addition, lymphopenia is common in an environment of severe inflammation (Cavaillon and Adib-Conquy, 2010, Girardot et al. , 2017) . It is commonly observed in patients suffering severe disease (Diao et al. , 2020 , Qin et al., 2020 , Shi et al., 2020b . The weight of evidence suggests that drastically reduced numbers of CD4 + T cells, CD8 + T cells, B cells and natural killer (NK) cells are characteristic of COVID-19 (Diao et al., 2020 , Qin et al., 2020 , Shi et al., 2020b . In addition, the degree of lymphopenia correlates with symptom severity (Cao, 2020 and

inversely with inflammatory markers such as TNF-alpha and IL-6, (Wen et al., 2020) .

Furthermore, remaining CD4 and CD8 T lymphocytes display signs of exhaustion and dysfunction as evidenced by increased expression of PD-1, Tim-3 and NKG2A receptors (Diao et al., 2020 , Moon, 2020 , Zheng et al. , 2020a . It should be noted that the extent of T cell exhaustion is predictive of greater disease severity (Zheng et al., 2020a) . 

There is ample evidence that SARS infects type 2 alveolar epithelial cells leading to their death by apoptosis and pyroptosis via the activation of NLP-3 through mechanisms described above (Mossel et al. , 2008 , Qian et al. , 2013 reviewed . This is also clearly true of SARS-CoV-2 (Fox et al., 2020 , Mason, 2020 , Tian et al., 2020 , Yang, 2020 , Yao et al. , 2020a , Yao et al., 2020b . Furthermore, the weight of evidence suggests that SARS-COV (La Gruta et al. , 2007 , Shinya et al. , 2012 and SARS-CoV-2 (Carsana et al., , Liao et al., 2020 , Mason, 2020 result in the activation of alveolar macrophages (AM). This is unsurprising, given the close proximity of these immune cells to type II pneumocytes and their expression of ACE-2 receptors (Fan and Fan, 2018 , Verdecchia et al., 2020 .

The loss of type II alveolar cells and AM activation has considerable pathophysiological importance resulting in the loss of immune homeostasis in the lung (Chakraborty et al. , 2017 , Gonzales et al., 2015 , Han and Mallampalli, 2015 . This dyshomeostasis in turn is an essential element in the development of severe pneumonia and the acute respiratory distress syndrome, which occurs as a consequence of virally J o u r n a l P r e -p r o o f 13 (HMBG1) and other inflammatory damage-associated molecular patterns (DAMPS) (Faust and Mangalmurti, 2020 , Sauler et al. , 2019 , Ueno et al. , 2004 . Hence, the pyroptotic death of type 2 alveolar cells following SARS-Cov2 infection may also be of pathophysiological significance in the development of COVID-19 and a major source of inflammation Fan, 2018, Huang et al., 2018) .

Activated macrophages (AMs) play a major role in maintaining immune homeostasis in the lung in the face of pathogen invasion and a myriad of inflammatory insults. The main mechanisms involved phagocytosis of dying cells, secretion of anti-inflammatory mediators such as transforming growth factor (TGF) beta, Prostaglandin E2 (PGE2) and polyenoic fatty acids (PFA), and inhibiting the activation of circulating T cells (reviewed in Fan, 2018, Huang et al., 2018) ). However, once activated, these AMs secrete a range of proinflammatory cytokines (PICs) and chemokines such as TNF-alpha IL-1 beta, IL-6, and IL-8 (Aberdein et al. , 2013 , Losa García et al. , 1999 ) (Aberdein et al., 2013 , Losa García et al., 1999 . In addition, AM's also secrete microvesicles, containing massive levels of TNF-alpha (Soni et al. , 2016) . This increase in the secretion of inflammatory mediators is also accompanied by an increase in the number of AMs polarised into a highly inflammatory or M1 phenotype rather than the anti-inflammatory tolerogenic M2 phenotype prevalent in physiological conditions (Morrell et al. , 2019 . This is of considerable pathophysiological importance as a progressively increased population of M1 polarised alveolar macrophages over time results in excessive secretion of PICs and chemokines, and is highly predictive of mortality in ARDS patients, while an increased population of M2 polarised cells is predictive of survival (Morrell et al., 2019 . Importantly, the subsequent release of these cytokines and chemokines into the pulmonary vasculature plays an important role in the development of ARDS by initiating J o u r n a l P r e -p r o o f 14 a series of events which results in the activation of vascular endothelial cells (EC) (Frantzeskaki et al. , 2017 , Han and Mallampalli, 2015 .This in turn leads to the recruitment of highly cytotoxic neutrophils and inflammatory activated platelets into the alveolar space, resulting in a host of pathogenic consequences, as discussed below (Frantzeskaki et al., 2017 , Han and Mallampalli, 2015 .

Increased levels of PICs such as TNF-alpha and IL-1 induce endothelial cell activation via the upregulation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) (Pober and Sessa, 2007, Szmitko et al. , 2003) , leading to a significant increase in the permeability of the pulmonary vascular endothelium (Sukriti et al. , 2014) . The activation of pulmonary vascular endothelial cell (ECs) also promotes the recruitment of circulating neutrophils via the upregulation of surface membrane chemokines, most notably CCL5, CXCL1, MCP-1 and IL-8, the surface adherence proteins P-selectin, VCAM-1, ICAM-1 and an array of glycosaminoglycans, which play an essential role in neutrophil tethering and migration (Cejkova et al. , 2016 , Mitroulis et al. , 2015 , Ramji and Davies, 2015 .

Once activated, vascular ECs behave in a similar manner to immune cells and become a source of PICs and reactive oxygen species (ROS) and also stimulate the activity of immune cells in the vascular environment, reviewed (Mai et al. , 2013) . Activated ECs also contribute to the development of coagulopathy via several mechanisms including the recruitment of platelets, independently secreting tissue factor and VWF, decreasing the activity of thrombomodulin and protein C while stimulating the activity of PAR-1, (reviewed by (Yau et al. , 2015) and (van Hinsbergh, 2012) ). The development of endotheliopathy is a major factor in the pathogenesis of systemic sepsis and a major player in the development and J o u r n a l P r e -p r o o f 15 exacerbation of the underlying cytokine storm (Chang, 2019 , Nedeva et al. , 2019 . Crucially, the development of endotheliopathy is also a pivotal factor in the pathogenesis of ARDS (Hendrickson and Matthay, 2018, Millar et al. , 2016) as we discuss below.

In addition, as the mechanics of the coagulation cascade play a large part in the forthcoming discussion, a diagram of the processes involved is provided in Figure 2 . Platelets activated by thrombin and or PICs initiate (PAR)-mediated signalling further increasing levels of PICs VWF and TF coupled with suppression of suppression of thrombomodulin. Platelet activation also results in increased expression of P-selectin, CD40 PF4 and a range of surface adhesion receptors ultimately recruiting neutrophils to form platelet neutrophil complexes. NET secretion by neutrophils contributes to an increased coagulation stimulate increased levels of platelet activation, aggregation and TF mediated activation of thrombin. In addition, histones play an important role in promoting thrombin generation and inhibiting protein C-mediated anticoagulant responses. PICs also play a role in the development of coagulopathy by inhibiting the protein C-protein S-thrombomodulin pathway and increasing the production of PAI-1. The combination of a hyperactivated coagulation cascade and the inhibition of anti-coagulant pathways, such as the protein C-J o u r n a l P r e -p r o o f protein S-thrombomodulin pathway and inhibition of the fibrinolytic system is characteristic of DIC. This state is also the source of micro emboli and excessive alveolar fibrin deposition in ARDS.

Platelets in the pulmonary vasculature are also targets for activation by the high levels of PICs and ROS secreted by alveolar macrophages and activated type II epithelial cells (Pignatelli et al. , 2005) ; (reviewed by (Qiao et al. , 2018) ). Activated platelets (AP) also become a significant source of PICs and ROS (El Haouari, 2019 , Freedman, 2008 , Violi et al. , 2010 reviewed in (Hamilos et al. , 2018) . Importantly, APs also secrete several chemokines, most notably RANTES, and CCL4, also known as platelet factor 4 (PF4), which increase neutrophil activation, survival, recruitment to the endothelium and subsequent tethering to EC (Øynebråten et al. , 2015, Sonmez and Sonmez, 2017) . Finally, AP also play a crucial role in mediating and exacerbating neutrophil mediated inflammatory responses in acute lung injury and systemic sepsis by binding directly to neutrophils, resulting in the formation of platelet neutrophil complexes (PNC) (Finsterbusch et al. , 2018 , Sreeramkumar et al. , 2014 , Stark, 2019 .

The formation of PNCs complexes in inflammatory conditions is initiated by the binding of Pselectin expressed on the surface of APs and P-selectin glycoprotein ligand-1 (PSGL-1) expressed on neutrophils followed by the binding between platelet glycoprotein Ibα and the neutrophil beta integrin, macrophage-1 antigen (MAC-1) (Sreeramkumar et al., 2014 (reviewed by (Zucoloto and Jenne, 2019) ). P-selectin also plays an important role in increasing neutrophil binding to ECs, thereby increasing neutrophil rolling while increasing expression of MAC-1 in PNCs, which increases neutrophil tethering and subsequent crawling (Etulain et al. , 2015 , Kornerup et al. , 2010 . There are other receptors J o u r n a l P r e -p r o o f 17 involved in the process and readers interested in a more detailed consideration of this topic are referred to excellent reviews by (Rayes et al. , 2020) and (Iba et al. , 2019) .

Evidence suggests that the formation of PNCs increases neutrophil recruitment, activation priming and the ultimate extraversion of these immune cells in an activated and primed state into inflamed lung tissue (Duerschmied et al. , 2013 , Ghasemzadeh and Hosseini, 2015 , Kornerup et al., 2010 , Maugeri et al. , 2012 , Page and Pitchford, 2013 . As previously discussed, this is a crucial element in the pathophysiology of ARDS (Frantzeskaki et al., 2017 , Han and Mallampalli, 2015 ., and understanding the mechanisms involved may identify therapeutic opportunities.

Briefly, PNCs have a reduced velocity compared to platelets and neutrophils alone and this property combined with increased endothelial adhesion increases the sequestration of neutrophils and platelets in the microvascular beds of the lung (Graham et al. , 2019 , Middleton et al. , 2016 , Ortiz-Muñoz et al. , 2014 . In addition, activated platelets and neutrophils engage in mutual amplification of PIC and ROS production, leading to an increased level of inflammation than would be achieved by either alone (Duerschmied et al., 2013 , Ghasemzadeh and Hosseini, 2015 , Kornerup et al., 2010 , Maugeri et al., 2012 , Page and Pitchford, 2013 . Sequestrated PNCs become a source of excessive PIC, ROS and chemokine production in the pulmonary vasculature in addition to the PICs, ROS and chemokines secreted by alveolar macrophages and type II epithelial cells and vascular ECs as discussed above. This facilitates neutrophil priming.

Priming may be induced by a range of cytokines, chemokines and growth factors such as TNF-alpha, IL-1 beta, IL-8 and granulocyte-macrophage colony-stimulating factor (GM-CSF), or engagement with activated endothelial cells (Yao et al. , 2015) . The mechanisms involved J o u r n a l P r e -p r o o f include major changes in phosphoinositide 3-kinase (PI3K) mitogen-activated protein kinases (MAPKs), phospholipase D and calcium level instigated signalling pathways (Hao et al. , 2012 , Vogt et al. , 2018 . Priming results in profound cytoskeletal reorganisation and a significant reduction in deformability and increased retention in pulmonary capillary beds (Summers et al. , 2014, Zemans and Matthay, 2017) . These are resistant to apoptosis and secrete massive levels of cytotoxic products including PICs, chemokines, proteases and NETs (Juss et al. , 2016 , Summers et al., 2014 . The association of platelets and neutrophils has pathological consequences other than increased sequestration of neutrophils into the lung.

In particular, there is ample evidence to confirm that increased sequestration of platelets and neutrophils in lung microvascular beds leads to the development of a pro-coagulant and proinflammatory environment (Graham et al., 2019 , Middleton et al., 2016 , Ortiz-Muñoz et al., 2014 . The mechanisms involved are discussed below.

Platelets complexed with neutrophils enhance their phagocytic capacity and their release of ROS and other cytotoxic molecules such as myeloperoxidase (MPO) (Assinger et al. , 2011 , Gros et al. , 2014 . Platelets also stimulate neutrophil production of NETs (Clark et al. , 2007 , Katz et al. , 2011 via a mechanism which involves inducing NETosis (Carestia et al. , 2015 , Etulain et al., 2015 , Maugeri et al. , 2014 . Mechanistically, this involves the secretion of high mobility group box 1 (HGMB1), which stimulates NET production via increasing receptor for advanced glycation endproducts (RAGE) mediated autophagy (Kim et al. , 2019 , Maugeri et al., 2014 , Ramirez et al. , 2019 . This DAMP also plays a major role in increasing NET production by increasing platelet activation via engagement with Toll-like receptor (TLR)-4, resulting in the formation of a positive feedback loop (Huebener et al. , 2015 , Stark, 2019 . HMBG1 also enhances neutrophil survival, neutrophil mediated tissue damage, and J o u r n a l P r e -p r o o f 19 contributes to the creation of a self-amplifying pattern of platelet activation and NET production (Huebener et al., 2015 , Ramirez et al., 2019 , Stark, 2019 .

In turn, NETs stimulate increased levels of platelet activation, aggregation and tissue factor (TF) mediated activation of thrombin, resulting in enhanced intravascular coagulation (Elaskalani et al. , 2018 , Fuchs et al. , 2010 , Zucoloto and Jenne, 2019 . Several mechanisms appear to underpin the contribution of NETs to thrombus formation including TF-and FXII- Over time, the combined effects of activated ECs, neutrophils and platelets, NETs and activated endothelial cells in the pulmonary alveo-capillary vasculature lead to the development of a highly inflammatory and pro-coagulant state typified by hyperactivation of the coagulation cascade and relative exhaustion of the fibrinolytic system with excessive production of PICs, DAMPS and fibrin deposition. This is described as immuno-thrombosis (Engelmann and Massberg, 2013 , Frantzeskaki et al., 2017 , Kimball et al. , 2016 . This state (Frantzeskaki et al., 2017 , Prabhakaran et al. , 2003 , Sapru et al. , 2010 , Xue et al. , 2015 , Yadav and Kor, 2015 . This subsequently increases both dead-space ventilation and intra-pulmonary shunting, both characteristic features of ARDS (Brun-Buisson et al. , 2004) (Doorduin et al. , 2016 , Ozolina et al. , 2016 , Sarkar et al. , 2017 . The development of exaggerated immunothrombosis and the failure of mechanisms required to anchor thrombi in the local environment also drive the development of DIC and readers interested in further details are referred to (Gando and Otomo, 2015, Ito, 2014) .

The activity of PNCs and the high levels of NET producing neutrophils resulting in immunothrombosis appears to be a plausible mechanism underpinning the development of grossly enhanced coagulation seen in COVID-19 ARDS. We now turn our attention to the development of hypercytokinemia and high rates of AM death and inflammatory lung tissue damage seen in such patients. We begin with the pathological consequences stemming from a high population of NET secreting neutrophils. These processes are depicted in Figure   3 . Initial infection and activation of type 2 alveolar cells and alveolar macrophages results in the secretion of IL-6, PICs and a wide range of chemokines which activate vascular endothelial cells and recruit peripheral activated NET producing neutrophils. Mechanistically this is achieved via the formation of platelet neutrophil complexes which become sequestrated in the lung microcapillaries creating a hyper coagulant and highly inflammatory environment within these blood vessels and the wider pulmonary circulation. The entry of neutrophils into the lung coupled with their prolonged survival results in the development of a cytokine storm with extreme tissue damage and lung dysfunction fuelled by an interplay between PICS DAMPS ROS, NLRPS activation, macrophage pyroptosis, influx of inflammatory monocytes and necroptosis.

As previously discussed, NETS are highly toxic to epithelial and endothelial cells and high (Ebrahimi et al. , 2018) . There are very high levels of NETS and neutrophils in the alveolar space of ventilated ARDS patients, with the latter secreting excessive levels of IL-6 ,IL-8 and CCL2, each playing a major role in increasing tissue damage either directly or via the recruitment of more neutrophils from the periphery (Mikacenic et al. , 2018) . It is, however, important to note that while the release of PICs and enzymes such as elastase and MPO from activated neutrophils makes a significant contribution to increasing inflammation and lung damage, the dominant players in this regard are the contents of NETs, most notably mtDNA, HGMB1 and histones (Brostjan and Oehler, 2020, Peng et al. , 2017) . Given their importance, the role of each in the pathophysiology of ARDS is briefly considered below.

Levels of extracellular histones are substantially higher in the bronchoalveolar lavage fluids (BALF) and plasma of ARDS patients, correlate with symptom severity and are predictive of mortality (Jin et al. , 2019 , Lv et al. , 2017 , Zhang et al. , 2013 . Histones function as a DAMP capable of activating membrane bound and cytosolic PPRs leading to the release of inflammatory mediators such as TNF-alpha, IL-1 and iNOS (Allam et al. , 2012 , Szatmary et al. , 2018 . These molecules are also efficient activators of the NLP3 inflammasome and inducers of immune and epithelial cell pyroptosis (Allam et al. , 2013) . This latter point is important as one mechanism underpinning the effects of histones in the development and exacerbation of ARDS involves NLRP3 activation and subsequent pyroptosis of peripheral macrophages resulting in significant increases in peripheral inflammation (Jin et al., 2019 , Lv et al., 2017 . Unsurprisingly, high levels of histones in the alveoli and the interstitial tissue of the lung also increases the activation of resident immune cells, epithelial cells and endothelial cells, and induces their death by pyroptosis and necrosis. This results in further J o u r n a l P r e -p r o o f 23 damage to the alveolar epithelium, vascular endothelium and enhances barrier dysfunction (Xu et al. , 2015) . Histones released from NETs or activated but otherwise viable immune cells also contribute to the pathophysiology of ARDS other than by directly inducing severe pulmonary tissue damage and increasing levels of peripheral inflammation such as activation of the complement and coagulation cascades (Standiford and Ward, 2016, Xu et al., 2015) .

The presence of mtDNA in the circulation is a marker of mortality in sepsis patients in the intensive care unit (Nakahira et al. , 2013 , Yan et al. , 2018 . In addition, levels of plasma mtDNA is predictive of the transition to ARDS (Faust et al. , 2020) and need for ventilation in this population (Simmons et al. , 2017) . Mechanistically, the role of mtDNA in the pathophysiology of sepsis and ARDS also stems from its activity as a DAMP capable of activating cytosolic TLR-9 receptors, stimulating the activation of the NLRP 3 inflammasome following release from mitochondria within stressed cells or when released into the extracellular environment by apoptosis, necrosis, pyroptosis and NETosis (reviewed by (Grazioli and Pugin, 2018) ).

High-mobility group protein 1 (HMBG-1) is another major player in the pathogenesis and pathophysiology of ARDS, and levels of this molecule in the blood are predictive of mortality in virally induced ARDS and severe pneumonia (Andersson and Tracey, 2011 , Tseng et al. , 2014 , Wang et al. , 2014a , Zhu et al. , 2010 . This heat shock protein also functions as a DAMP and plays a major role in the propagation and exacerbation of sterile inflammation and in the development of sepsis (Pisetsky, 2014) . In addition, HMBG1 appears to be the dominant driver of inflammation resulting from cell necrosis and proptosis, and there is J o u r n a l P r e -p r o o f 24 evidence to suggest that its role in the development of ARDS may be multidimensional. The association between increased HGMB1 levels and accelerated NET production by neutrophils has been discussed. This cytokine also exerts a pathological effect in the development of ARDS by aiding in delayed NET clearance, which is a distinctive element driving the development and acceleration of the condition (Grégoire et al. , 2018, Scott and Kubes, 2018) . Ultimately, the decreased clearance of NETs is a consequence of delayed neutrophil apoptosis (Grégoire et al., 2018, Scott and Kubes, 2018) which is discussed below.

Several research teams have reported delayed neutrophil apoptosis and clearance of NETS in patients with sepsis related ARDS (Duffin et al. , 2010 , Fialkow et al. , 2006 , Galluzzi et al. , 2018 , Matute-Bello et al. , 2000 . In addition, the percentage of the neutrophil population displaying markers of delayed apoptosis correlates with the severity of symptoms and several objective measures of tissue damage (Duffin et al., 2010 , Fialkow et al., 2006 , Galluzzi et al., 2018 , Matute-Bello et al., 2000 and survival (Sauler et al., 2019) . Delayed apoptosis is also accompanied by serious pathological consequences as the phenomenon may lead to neutrophil pyroptosis Sun, 2019, Ryu et al. , 2017) or, in some instances, necroptosis (Germic et al. , 2019 with increases in highly oxidised mtDNA, histones, HMBG1, PICs and a swathe of other inflammatory molecules (Germic et al., 2019 , Yousefi et al. , 2009 . Importantly, delayed neutrophil apoptosis acts as an additional source of increasing inflammation further exacerbating cell death and tissue damage (Grecian et al. , 2018) ; review (Brostjan and Oehler, 2020).

J o u r n a l P r e -p r o o f 25 Spirally increasing levels of HMBG1 may contribute to decreased neutrophil clearance in ARDS patients by inhibiting neutrophil apoptosis (Friggeri et al. , 2010 , Liu et al. , 2008 , Schaper et al. , 2016 . In addition, increased levels of HMGB1 produced by the activity of NETS stimulates the release of NETS by other neutrophils increasing the population of neutrophils resistant to apoptosis in the lung. This results in a significant increase in inflammation and tissue damage, creating one of many feedforward loops involved in the progression of ARDS (Huebener et al., 2015 , Kim et al., 2019 .

Another, and perhaps predominant cause of prolonged neutrophil survival and sub-optimal NET clearance in many patients suffering from ARDS would appear to be impaired alveolar macrophage phagocytic clearance of dying cells or efferocytosis (Grégoire et al., 2018 , Mahida and Thickett, 2018a , Mahida and Thickett, 2018b , Potey et al. , 2019 . This phenomenon has serious pathological consequences since in physiological conditions, alveolar macrophages play an indispensable role in the immunologically silent removal of neutrophils and the adoption of an anti-inflammatory profile by macrophages (Elliott et al. , 2017 , Greenlee-Wacker, 2016 , Silva, 2011 . In addition, macrophage efferocytosis plays a major role in the clearance of NETs (Boe et al. , 2015, Farrera and Fadeel, 2013) .

The weight of evidence suggests that high levels of HGMB1 is an important if not predominant driver of impaired alveolar macrophage efferocytosis seen in several lung disease including ARDS (Friggeri et al., 2010 , Liu et al., 2008 , Schaper et al., 2016 . Clearly, increased NET generation is a major source of HGMB1, but it should be noted that there are also other sources of this molecule in ARDS patients which is relevant in the COVID-19 model proposed here. Such sources include alveolar macrophages, dendritic cells, alveolar J o u r n a l P r e -p r o o f 26 epithelial cells and alveolar endothelial cells activated in response to viral activation or high levels of TNF-alpha (Ding et al. , 2017 , Kim et al. , 2015 , Ma et al. , 2016 , Smit et al. , 2014 .

High levels of TNF-alpha may also contribute to delayed neutrophil apoptosis and impaired alveolar macrophage efferocytosis in ARDS patients. Excessive levels of environmental TNFalpha is a well-documented cause of compromised phagocytosis in these immune cells (McPhillips et al. , 2007 , Michlewska et al. , 2009 ). In addition, high levels of HMBG1 may increase the population of M1 polarised macrophages via a mechanism involving TLR-4 and RAGE activation , Schaper et al., 2016 , Su et al. , 2016 , Wang et al. , 2020d . This is of importance from the perspective of impaired efferocytosis, as macrophages polarised in such a manner display inhibited phagocytosis compared to their M2 polarised counterparts (Yao et al. , 2019) . Increased polarisation of M1 polarisation is also driven by Clearly an increasing interplay between DAMPS, cytokines and ROS secreted by epithelial cells, neutrophils and alveolar macrophages can explain high levels of inflammation and lung tissue damage seen in ARDS secondary to sepsis and COVID-19. This theme will continue to be explored in the following section which focuses on the interplay between DAMPS, TLRs, NOD-like receptors (NLRs), PIC and ROS and various forms of necrotic cell death in the development of a cytokine storm. The interplay between DAMPS and pattern recognition receptors plays a pivotal role in this process.

HMGM1, often described as the prototypical DAMP, may contribute to the development of acute or chronic lung injury by activating TLR-4, TLR-2 and RAGE receptors resulting in the activation of MAP Kinases and ERK, and culminating in the nuclear translocation of NF-kB J o u r n a l P r e -p r o o f 27 resulting in increased production of PICs and ROS (Guijarro-Muñoz et al. , 2013 , He et al. , 2013 , Mulrennan et al. , 2015 , Pusterla et al. , 2013 . Increased levels of PICs in turn induce the release of HMBG1 from immune and epithelial cells and directly cause a self-amplifying cascade of inflammation, oxidative stress and lung tissue damage (Entezari et al. , 2014 , Luan et al. , 2018 ; (reviewed by (Qu et al. , 2019) ). This process is likely central to the development of chronic, escalating inflammation and tissue damage in many illnesses such as multiple sclerosis, rheumatoid arthritis and major depression and has been described as the Toll-like Receptor Radical Cycle .

In the context of ARDS, the weight of evidence suggests that excessive PIC and ROS damage to cellular proteins and DNA also results in massively increased intracellular mtROS production and the subsequent activation of the NLPR 3 inflammasome (Long et al. , 2020 . This is an important point as inflammasome activation and the release of IL-1 and IL-18 appear to make a significant contribution to the development and progression of ARDS in the later stages of disease and high levels of the latter cytokine is associated with an extremely poor prognosis (Dolinay et al. , 2012 , Grailer et al. , 2014 , Makabe et al. , 2012 . This is perhaps unsurprising given data highlighting the indispensable role of NLRP-3 activation in the progression of ARDS (Grailer et al., 2014) and sepsis (Kumar, 2018) . In addition information gleaned from animal studies suggests that the inhibition of this inflammasome is associated with increased rates of survival (Jin et al. , 2017 , Kim et al. , 2016 (reviewed by (Danielski et al. , 2020) ). There would appear to be many elements underpinning the association between increased inflammasome activity and mortality in ARDS patients. Perhaps the most important is spirally increasing cell death by pyroptosis and necrosis, most notably in macrophages and epithelial cells (Long et al., 2020 . 

As previously discussed, pyroptosis and necroptosis of alveolar epithelial and endothelial cells are major elements in the development and progression of ARDS (Faust and Mangalmurti, 2020 , Sauler et al., 2019 , Ueno et al., 2004 . There is also evidence to suggest that the pyroptotic death of neutrophils makes an independent contribution to the exacerbation of inflammation in more advanced stages of the condition (Liu and Sun, 2019) .

However, from the perspective of ARDS related mortality, perhaps the most important element is the pyroptosis of alveolar macrophages (Fan and Fan, 2018 , Hou et al. , 2018 , Traeger et al. , 2009 , Wu et al. , 2015 . Indeed, high levels of AM pyroptosis is another marker of mortality in patients with ARDS (Zhang and Coopersmith, 2018) .

There is ample evidence to suggest that excessive loss of AMs as result of death via pyroptosis, or necrosis, plays an important role in the development and acceleration of lung damage by contribution to auto-inflammatory pathways , Linkermann et al. , 2014 , Xu et al. , 2014 . The mechanisms underpinning these observations would appear to be twofold. Firstly, the loss of resident AMs results in a repopulation of AMs derived from highly inflammatory peripheral monocytes which display grossly reduced phagocytic capacity, increased production of inflammatory mediators and susceptibility to pyroptosis and other forms of cell death (McQuattie-Pimentel et al. , 2018, Schulz et al. , 2019) (reviewed by (Hu and Christman, 2019) ). Secondly, accelerated pyroptosis of the AM population, results in ever increasing levels of DAMPS, PIC and ROS in turn resulting in spirally increasing tissue damage (Wang et al. , 2001 , Xu et al., 2014 , Yang et al. , 2005 ;

(reviewed by (Fan and Fan, 2018) ). The weight of evidence suggests that HMBG1 may well be the dominant driver of the inflammatory responses following pyroptotic cell death, as inhibition of this molecule significantly decreases such responses (Vande Walle et al. , 2011). J o u r n a l P r e -p r o o f 29 Given this and the other information discussed above, it seems reasonable to conclude that interventions capable of decreasing the activity and or production of this heat shock protein may well have importance in the prevention and potentially the resolution of ARDS.

There is now accumulating evidence to suggest that the escalating increases in levels of IL-6, TNF-alpha, nitric oxide (NO) and ROS secreted by macrophages (Aberdein et al., 2013 , Losa García et al., 1999 also make a significant contributions to mortality by stimulating widespread cellular RIPK mediated necroptosis Mangalmurti, 2020, Yang et al., 2018) . This form of cell death is associated with massive increases in levels of HGMB1, mtDNA, PICs, chemokines and ROS with ever amplifying levels of tissue damage, described as necroinflammation (Newton and Manning, 2016, Zhu et al. , 2018) , leading to irreversible lung failure (Wang et al. , 2017a) . Necroptosis is predictive of non-resolving ARDS and mortality in patients on mechanical ventilation Mangalmurti, 2020, Yang et al., 2018) . The pathological consequences of programmed cell death are difficult to overstate as studies have reported a causative association between the advent of widespread RIP Kinase-dependent necroptosis and the development of multiple organ failure and death in systemic inflammatory response syndrome and sepsis (Reilly et al. , 2016) . Elevated levels of RIP-3 in the blood is an almost invariant marker of a cytokine storm and is predictive of multiple organ failure and death. (Duprez et al. , 2011 , Schenck et al. , 2019 . The mechanisms underpinning the development of necroptosis are relatively complex and readers interested in the biochemistry involved are referred to comprehensive reviews by (Morris et al. , 2018c) and (Sarhan et al. , 2018) and the matter will not be considered further here. However of note a recent study has revealed the existence of a positive feedback loop between pyroptosis and necroptosis which leads to J o u r n a l P r e -p r o o f 30 even higher levels of tissue damage and dysfunction (Chen et al. , 2020a) . This data further emphasises the importance of NLRP3 activation in the pathophysiology of ARDS and highlights the widespread inhibition of this inflammasome as a highly desirable therapeutic target.

An environment of severe chronic inflammation and oxidative stress seen in patients in advanced ARDS can lead to lymphopenia, compromised leucocyte function and a high Th17:regulatory T cell (T reg) ratio (Maj et al. , 2017 , Moro-García et al. , 2018 , Morris et al. , 2013b , Morris et al. , 2014 , Morris et al. , 2018a , Saeidi et al. , 2018 contributing to the pathophysiology of the condition.

T regs play an important role in the prevention and resolution of ARDS via several routes such as promoting neutrophil clearance, inhibiting the effects of IL-6 and promoting the M2 polarisation of alveolar macrophages (Lin et al. , 2018) . T regs also act as a cytokine sink and ameliorates otherwise uncontrolled inflammation via the secretion of IL-10 and TGF beta with a resultant downregulation in the production of TNF-alpha and IL-1 beta by resident and infiltrating macrophages (Lin et al., 2018 , Wong et al. , 2019 .

TH17 polarised T cells also play a pathological role in the development and exacerbation of ARDS (Wong et al., 2019) . The main mechanism underpinning this association is increased production of IL-17 (Giamarellos-Bourboulis et al., , Pedersen and Ho, 2020 . This is a highly cytotoxic molecule capable of causing significant levels of tissue damage and plays a major role in the recruitment of neutrophils from the periphery (Mikacenic et al. , 2016) . High levels of IL-17 is a marker for a poor prognosis in patients with ARDS (Mikacenic et al., 2016) . The importance of Th17 and T regs in the pathophysiology of J o u r n a l P r e -p r o o f 31 ARDS is emphasised by data suggesting that the TH17:T reg ratio is predictive of 28 day mortality in ventilated ARDS patients (Mikacenic et al., 2016) A suggested therapeutic approach to treatment Many of the elements involved in the pathophysiology of ARDS are dependent on the chronic or long-term activation of NF-κB. For example there is copious evidence that activated NF-κB plays an important if not indispensable role in the initiation of platelet activation and maintaining such platelets in that state (Chang et al. , 2011 , Lu et al. , 2011 , Lu et al. , 2012 , Malaver et al. , 2009 , Spinelli et al. , 2010 . Activated NF-κB plays an indispensable role in the production, survival, and activation of neutrophils (von Vietinghoff et al. , 2010 , Wang et al. , 2009 and their release of NETs (Lapponi et al. , 2013 , Mohammed et al. , 2013 . Chronically upregulated NF-κB is also an essential element enabling the activation of alveolar macrophages (Moine et al. , 2000 , Schwartz et al. , 1996 . This is also true of monocyte activation and their subsequent differentiation into macrophages (Liu et al. , 2017a , Takashiba et al. , 1999 . Inflammasome activation is also dependent on the upregulation of NF-κB , Liu et al., 2017a . Importantly there is an accumulating body of evidence implicating elevated NF-κB in the pathogenesis and progression of ARDS (Gao et al. , 2017 , Mishra et al. , 2016 , Pooladanda et al. , 2019 , Umberto Meduri et al. , 2011 .

In addition there is a wealth of evidence to suggest that the maintenance and progression of ARDS also requires the presence of systemic sepsis or at the least excessive levels of systemic inflammation (Fan and Fan, 2018 , Han and Mallampalli, 2015 , Meduri et al. , 2009 ). This is important as there is considerable evidence of sepsis in patients with severe COVID-19 and that chronic activation of NF-κB in the development and progression of systemic sepsis (reviewed by (Liu and Malik, 2006) ). Hence the localised suppression of NF-κB would J o u r n a l P r e -p r o o f 32 seem to be an attractive option and (Steinhagen et al. , 2020) (reviewed by (Nedeva et al., 2019) ).

The weight of evidence suggests that Zinc (Zn) is a highly effective NF-κB inhibitor in vivo (Bao et al. , 2010 , Knoell and Liu, 2010 . This is of particular interest as several authors have reported grossly depleted Zn levels in patients with severe infections, sepsis and ARDS hence there is a case for Zn supplementation in COVID-19 (Besecker et al. , 2011 , Cirino Ruocco et al. , 2018 , Wong et al. , 2007 . It is also noteworthy that vitamin C levels are also commonly depleted in patients with sepsis and ARDS (Ang et al. , 2018 , Kuhn et al. , 2018 and several authors have reported downregulation of NF-κB following its administration (Cárcamo et al. , 2002 , Ichim et al. , 2011 . Vitamin D is also severely depleted in many patients with sepsis and ARDS (Kempker et al. , 2012 , Nair et al. , 2018 and dietary supplementation with this molecule also results in significant inhibition of NF-κB (Bergholm et al. , 2002 , Csiszar et al. , 2008 , Goncalves-Mendes et al. , 2019 , Ishii et al. , 2000 , Ni et al. , 2014 . There is also growing interest in vitamin D supplementation in treating COVID-19 following the publication of a paper reporting severely depleted levels of this vitamin in patients with COVID-19 pneumonia and COVID-19 ARDS (Ilie et al. , 2020) .

There are several other molecules with a proven pedigree as NF-κB inhibitors such as azithromycin (AZM) (Aghai et al. , 2007 , Stellari et al. , 2014 , curcumin, melatonin and coenzyme Q 10 (Morris et al. , 2013a , Morris et al. , 2019 , Morris et al. , 2018b .This is also true of N-acetyl-cysteine (Farid et al. , 2005 , Paterson et al. , 2003 , Wu et al. , 2014 . There is also evidence that aspirin is an effective NF-κB inhibitor (Liu et al. , 2017b, Sham et al. , J o u r n a l P r e -p r o o f 33 2018, Wang et al. , 2014b) although it should be emphasised that doses in excess of 300mg/day are needed to exert this effect in vivo (Liao et al. , 2015 , Ornelas et al. , 2017 .

A detailed and highly plausible model has been put forward in this paper demonstrating the pathophysiological steps of COVID-19 from the initial infection of type II alveolar epithelial cells by SARS-CoV-2 to the development of ARDS. There are various control points in this model at which interventions might be of therapeutic value. These include inhibition of EC platelet and neutrophil activation, inhibition of neutrophil migration and NET production, stimulation of AM phagocytosis, and inhibition of the NLRP3 inflammasome. These objectives might all be achieved via the concomitant use of one or more NF-κB inhibitors. A trial investigating the combined use of Zinc, vitamin C and vitamin D would seem to be a rational option given their depleted levels in patients with sepsis and ARDS and their potential as inhibitors of NF-κB. In addition, one or more of the NF-κB inhibitors discussed above might also be considered given their benign side effect profile and the difficulty of treating ARDS once the condition has arisen. 

Inflammation and endothelial dysfunction during aging: role of NF-kappaB

The NLRP3 Inflammasome and Its Role in Sepsis Development

SARS and MERS: recent insights into emerging coronaviruses

Polarization of Rheumatoid Macrophages by TNF Targeting Through an IL-10/STAT3 Mechanism

Blood platelets and sepsis pathophysiology: A new therapeutic prospect in critically [corrected] ill patients? Annals of intensive care

Reduction and Functional Exhaustion of T Cells in Patients with Coronavirus Disease

Emerging role of HMGB1 in lung diseases: friend or foe

Inflammasomeregulated cytokines are critical mediators of acute lung injury

Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong

Assessment of dead-space ventilation in patients with acute respiratory distress syndrome: a prospective observational study

Platelet serotonin promotes the recruitment of neutrophils to sites of acute inflammation in mice

Targeting granulocyte apoptosis: mechanisms, models, and therapies

RIP Kinase-Dependent Necrosis Drives Lethal Systemic Inflammatory Response Syndrome

Markers of neutrophil extracellular traps predict adverse outcome in community-acquired pneumonia: secondary analysis of a randomised controlled trial

Platelet Oxidative Stress and its Relationship with Cardiovascular Diseases in Type 2 Diabetes Mellitus Patients

Neutrophil extracellular traps induce aggregation of washed human platelets independently of extracellular DNA and histones

Efferocytosis Signaling in the Regulation of Macrophage Inflammatory Responses

Thrombosis as an intravascular effector of innate immunity

Inhibition of extracellular HMGB1 attenuates hyperoxia-induced inflammatory acute lung injury

P-selectin promotes neutrophil extracellular trap formation in mice

Regulation of alveolar macrophage death in acute lung inflammation

Effects of dietary curcumin or N-acetylcysteine on NF-κB activity and contractile performance in ambulatory and unloaded murine soleus

Macrophage Clearance of Neutrophil Extracellular Traps Is a Silent Process

Collateral damage: necroptosis in the development of lung injury

Neutrophil apoptosis: a marker of disease severity in sepsis and sepsis-induced acute respiratory distress syndrome

Measuring and interpreting platelet-leukocyte aggregates

Vander Heide RS. Pulmonary and Cardiac Pathology in Covid-19: The First Autopsy Series from New Orleans

Immunothrombosis in Acute Respiratory Distress Syndrome: Cross Talks between Inflammation and Coagulation

Oxidative stress and platelets. Arteriosclerosis, thrombosis, and vascular biology

HMGB1 inhibits macrophage activity in efferocytosis through binding to the alphavbeta3-integrin

Extracellular DNA traps promote thrombosis

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death

Local hemostasis, immunothrombosis, and systemic disseminated intravascular coagulation in trauma and traumatic shock

Resolvin D1 Improves the Resolution of Inflammation via Activating NF-κB p50/p50-Mediated Cyclooxygenase-2 Expression in Acute Respiratory Distress Syndrome

COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Medicine

Covid-19 Does Not Lead to a "Typical" Acute Respiratory Distress Syndrome

Regulation of the innate immune system by autophagy: neutrophils, eosinophils, mast cells, NK cells

Intravascular leukocyte migration through platelet thrombi: directing leukocytes to sites of vascular injury

Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure. Cell host & microbe

Apoptosis-induced lymphopenia in sepsis and other severe injuries

Impact of Vitamin D Supplementation on Influenza Vaccine Response and Immune Functions in Deficient Elderly Persons: A Randomized Placebo-Controlled Trial

The Acute Respiratory Distress Syndrome: Mechanisms and Perspective Therapeutic Approaches

Leukocyte Adhesion: Reconceptualizing Chemokine Presentation by Glycosaminoglycans

Critical role for the NLRP3 inflammasome during acute lung injury

Mitochondrial Damage-Associated Molecular Patterns: From Inflammatory Signaling to Human Diseases

The role of neutrophils in cancer

Clearance of apoptotic neutrophils and resolution of inflammation

Impaired efferocytosis and neutrophil extracellular trap clearance by macrophages in ARDS

Platelets in inflammation: regulation of leukocyte activities and vascular repair

Lipopolysaccharide Activates Toll-like Receptor 4 (TLR4)-mediated NF-κB Signaling Pathway and Proinflammatory Response in Human Pericytes

Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)

Interaction between platelets and endothelium: from pathophysiology to new therapeutic options. Cardiovascular diagnosis and therapy

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

The acute respiratory distress syndrome: from mechanism to translation

ERK and PI3K signaling pathways are involved in C5a-primed neutrophils for ANCA-mediated activation

Temporal dynamics in viral shedding and transmissibility of COVID-19

Mechanism and Regulation of NLRP3 Inflammasome Activation

HMGB1 Acts in Synergy with Lipopolysaccharide in Activating Rheumatoid Synovial Fibroblasts via p38 MAPK and NF-κB Signaling Pathways

Endothelial biomarkers in human sepsis: pathogenesis and prognosis for ARDS

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

NLRP3/ASC-mediated alveolar macrophage pyroptosis enhances HMGB1 secretion in acute lung injury induced by cardiopulmonary bypass

Editorial: Alveolar Macrophages in Lung Inflammation and Resolution

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

The Role of Macrophages in the Pathogenesis of ALI/ARDS

The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis

Sepsis-associated disseminated intravascular coagulation and its differential diagnoses

Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?

The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality

Transcription Factor Nrf2 Coordinately Regulates a Group of Oxidative Stress-inducible Genes in Macrophages

PAMPs and DAMPs as triggers for DIC

Circulating Extracellular DNA: Cause or Consequence of Thrombosis? Seminars in thrombosis and hemostasis

Deletion of Nlrp3 Augments Survival during Polymicrobial Sepsis by Decreasing Autophagy and Enhancing Phagocytosis

Acute Respiratory Distress Syndrome Neutrophils Have a Distinct Phenotype and Are Resistant to Phosphoinositide 3-Kinase Inhibition. American journal of respiratory and critical care medicine

Beyond thrombosis: the versatile platelet in critical illness

Vitamin D and sepsis: An emerging relationship

Role of host cellular proteases in the pathogenesis of influenza and influenza-induced multiple organ failure

Combinational delivery of HMGB1 A box and heparin for acute lung injury

SESN2/sestrin2 suppresses sepsis by inducing mitophagy and inhibiting NLRP3 activation in macrophages

Neutrophil extracellular trap induced by HMGB1 exacerbates damages in the ischemic brain

The Emerging Role of NETs in Venous Thrombosis and Immunothrombosis

Impact of zinc metabolism on innate immune function in the setting of sepsis. International journal for vitamin and nutrition research Internationale Zeitschrift fur Vitamin-und Ernahrungsforschung Journal international de vitaminologie et de nutrition

SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is further increased by a naturally occurring elongation variant

Circulating platelet-neutrophil complexes are important for subsequent neutrophil activation and migration

Vitamin C in sepsis

Inflammasomes: Pandora's box for sepsis

A question of self-preservation: immunopathology in influenza virus infection

Regulation of neutrophil extracellular trap formation by anti-inflammatory drugs

Production and application of HMGB1 derived recombinant RAGE-antagonist peptide for anti-inflammatory therapy in acute lung injury

SARS-CoV-2 and viral sepsis: observations and hypotheses. The Lancet

High-mobility group box 1 protein participates in acute lung injury by activating protein kinase R and inducing M1 polarization

Tissue damage negatively regulates LPS-induced macrophage necroptosis

Aspirin Suppresses the Growth and Metastasis of Osteosarcoma through the NF-κB Pathway

The landscape of lung bronchoalveolar immune cells in COVID-19 revealed by single-cell RNA sequencing

Regulatory T Cells and Acute Lung Injury: Cytokines, Uncontrolled Inflammation, and Therapeutic Implications

Regulated cell death and inflammation: an auto-amplification loop causes organ failure

Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?

High mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserine

Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV

Epidemiological and Clinical Characteristics of Patients With Coronavirus Disease-2019 in Shiyan City

Neutrophil pyroptosis: new perspectives on sepsis

Zinc regulates the acute phase response and serum amyloid A production in response to sepsis through JAK-STAT3 signaling

The cytokine storm of severe influenza and development of immunomodulatory therapy

NF-kappa B activation as a pathological mechanism of septic shock and inflammation

NF-κB signaling in inflammation

Lipoxin A4 and its analog suppress inflammation by modulating HMGB1 translocation and expression in psoriasis

Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. The Journal of infection

The reproductive number of COVID-19 is higher compared to SARS coronavirus

ROS-induced NLRP3 inflammasome priming and activation mediate PCB 118-induced pyroptosis in endothelial cells

Evaluation of inflammatory cytokine secretion by human alveolar macrophages

A novel role of andrographolide, an NF-kappa B inhibitor, on inhibition of platelet activation: the pivotal mechanisms of endothelial nitric oxide synthase/cyclic GMP

Suppression of NF-κB signaling by andrographolide with a novel mechanism in human platelets: Regulatory roles of the p38 MAPK-hydroxyl radical-ERK2 cascade

Unfractionated Heparin Alleviates Human Lung Endothelial Barrier Dysfunction Induced by High Mobility Group Box 1 Through Regulation of P38-GSK3β-Snail Signaling Pathway

The Toll-Like Receptor Radical Cycle Pathway: A New Drug Target in Immune-Related Chronic Fatigue

IL-6 influences the balance between M1 and M2 macrophages in a mouse model of irritant contact dermatitis

Extracellular histones are clinically relevant mediators in the pathogenesis of acute respiratory distress syndrome

Circulating RIPK3 levels are associated with mortality and organ failure during critical illness

High-mobility group box 1 potentiates antineutrophil cytoplasmic antibody-inducing neutrophil extracellular traps formation

Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate

Differential effect of ARDS on alveolar macrophage efferocytosis compared to bacterial phagocytosis

Impaired Alveolar Macrophage Efferocytosis in ARDS causes accumulation of apoptotic neutrophils & prolonged inflammation

An evolving new paradigm: endothelial cells -conditional innate immune cells

Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor

Interleukin-18 levels reflect the long-term prognosis of acute lung injury and acute respiratory distress syndrome

NF-κB inhibitors impair platelet activation responses

Thrombosis: tangled up in NETs

Pathogenesis of COVID-19 from a cell biologic perspective

Modulation of neutrophil apoptosis by granulocyte colony-stimulating factor and granulocyte/macrophage colonystimulating factor during the course of acute respiratory distress syndrome

Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps

An intense and short-lasting burst of neutrophil activation differentiates early acute myocardial infarction from systemic inflammatory syndromes

TNF-alpha inhibits macrophage clearance of apoptotic cells via cytosolic phospholipase A2 and oxidant-dependent mechanisms

Monocyte-derived Alveolar Macrophages: The Dark Side of Lung Repair? American journal of respiratory cell and molecular biology

Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy

COVID-19: consider cytokine storm syndromes and immunosuppression

Macrophage phagocytosis of apoptotic neutrophils is critically regulated by the opposing actions of pro-inflammatory and anti-inflammatory agents: key role for TNF-alpha

Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases

Interleukin-17A Is Associated With Alveolar Inflammation and Poor Outcomes in Acute Respiratory Distress Syndrome

Neutrophil extracellular traps (NETs) are increased in the alveolar spaces of patients with ventilator-associated pneumonia

The pulmonary endothelium in acute respiratory distress syndrome: insights and therapeutic opportunities

c-Jun Is Required for Nuclear Factor-kappaB-Dependent, LPS-Stimulated Fos-Related Antigen-1 Transcription in Alveolar Macrophages

Leukocyte integrins: role in leukocyte recruitment and as therapeutic targets in inflammatory disease

Vitamin C: a novel regulator of neutrophil extracellular trap formation

NF-kappaB regulatory mechanisms in alveolar macrophages from patients with acute respiratory distress syndrome

Fighting COVID-19 exhausts T cells

Cytokine release syndrome in severe COVID-19. Science. 2020:eabb8925

Alveolar Macrophage Transcriptional Programs Are Associated with Outcomes in Acute Respiratory Distress Syndrome

Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications

A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and sickness behavior

The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs)

Myalgic encephalomyelitis/chronic fatigue syndrome: From pathophysiological insights to novel therapeutic opportunities

Multiple Immune-Inflammatory and Oxidative and Nitrosative Stress Pathways Explain the Frequent Presence of Depression in Multiple Sclerosis

The putative role of oxidative stress and inflammation in the pathophysiology of sleep dysfunction across neuropsychiatric disorders: Focus on chronic fatigue syndrome, bipolar disorder and multiple sclerosis

Cell Death Pathways: a Novel Therapeutic Approach for Neuroscientists

SARS-CoV replicates in primary human alveolar type II cell cultures but not in type I-like cells

The Role of Receptor for Advanced Glycation End Products in Airway Inflammation in CF and CF related Diabetes

Vitamin D status and supplementation in adult patients receiving extracorporeal membrane oxygenation

Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validation

Inflammation Is a Necessary Evil

Necroptosis and Inflammation

Elimination of vitamin D receptor in vascular endothelial cells alters vascular function

Weak Induction of Interferon Expression by SARS-CoV-2 Supports Clinical Trials of Interferon Lambda to Treat Early COVID-19

Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention

Aspirin-triggered 15-epilipoxin A4 regulates neutrophil-platelet aggregation and attenuates acute lung injury in mice

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

Activation of Coagulation and Fibrinolysis in Acute Respiratory Distress Syndrome: A Prospective Pilot Study

Neutrophil and platelet complexes and their relevance to neutrophil recruitment and activation

The effect of N-acetylcysteine on nuclear factor-κB activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis*

SARS-CoV-2: a storm is raging

Mineral particles stimulate innate immunity through neutrophil extracellular traps containing HMGB1

COVID-19, SARS and MERS: are they closely related?

Biological basis and pathological relevance of microvascular thrombosis

Tumor necrosis factor-alpha as trigger of platelet activation in patients with heart failure

The translocation of nuclear molecules during inflammation and cell death

Evolving functions of endothelial cells in inflammation

Nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting TNF-α mediated NF-κB and HDAC-3 nuclear translocation

Neutrophils in the initiation and resolution of acute pulmonary inflammation: understanding biological function and therapeutic potential

Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury

Receptor for advanced glycation endproducts (RAGE) is a key regulator of oval cell activation and inflammation-associated liver carcinogenesis in mice

Innate immune response of human alveolar type II cells infected with severe acute respiratory syndrome-coronavirus

Review of antibiotic resistance in China and its environment

Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clinical Infectious Diseases

High-Mobility Group Box 1 (HMGB1) and Autophagy in Acute Lung Injury (ALI): A Review

Misunderstandings Between Platelets and Neutrophils Build in Chronic Inflammation

Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets

The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome

The dual role of platelet-innate immune cell interactions in thrombo-inflammation. Research and Practice in Thrombosis and Haemostasis

1344: PLASMA RIP3, A REGULATOR OF NECROPTOSIS, IS ASSOCIATED WITH MORTALITY & ORGAN DYSFUNCTION IN SEPSIS

Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany

Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Medicine

Neutrophil pyroptosis mediates pathology of P. aeruginosa lung infection in the absence of the NADPH oxidase NOX2

T-Cell Exhaustion in Chronic Infections: Reversing the State of Exhaustion and Reinvigorating Optimal Protective Immune Responses

Type 1 interferons as a potential treatment against COVID-19

Dysregulation of lung myeloid cells in COVID-19

Elevated PAI-1 is associated with poor clinical outcomes in pediatric patients with acute lung injury

Origin and Consequences of Necroinflammation

Mechanisms of hypoxemia

Cell Death in the Lung: The Apoptosis-Necroptosis Axis

High mobility group box 1 skews macrophage polarization and negatively influences phagocytosis of apoptotic cells

Circulating cell death biomarker TRAIL is associated with increased organ dysfunction in sepsis

In-Depth Characterization of Monocyte-Derived Macrophages using a Mass Cytometry-Based Phagocytosis Assay

Nuclear factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndrome

Death to the neutrophil! A resolution for acute respiratory distress syndrome?

15-epi-Lipoxin A(4), Resolvin D2, and Resolvin D3 Induce NF-κB Regulators in Bacterial Pneumonia

Genome-level longitudinal expression of signaling pathways and gene networks in pediatric septic shock

Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China

COVID-19 infection: the perspectives on immune responses

Integrated Clinical, Pathologic, Virologic, and Transcriptomic Analysis of H5N1 Influenza Virus-Induced Viral Pneumonia in the Rhesus Macaque

Macrophage phagocytosis of neutrophils at inflammatory/infectious foci: a cooperative mechanism in the control of infection and infectious inflammation

Mitochondrial DNA damage associated molecular patterns in ventilator-associated pneumonia: Prevention and reversal by intratracheal DNase I

Dietary advanced glycation end-products, its pulmonary receptor, and high mobility group box 1 in aspiration lung injury

NETs promote ALI/ARDS inflammation by regulating alveolar macrophage polarization

Alveolar macrophage-derived microvesicles mediate acute lung injury

Role of platelets in immune system and inflammation

Platelets and megakaryocytes contain functional nuclear factor-kappaB. Arteriosclerosis, thrombosis, and vascular biology

Neutrophils scan for activated platelets to initiate inflammation

Therapeutic targeting of acute lung injury and acute respiratory distress syndrome. Translational research : the journal of laboratory and clinical medicine

Immunotherapy in sepsisbrake or accelerate?

Azithromycin inhibits nuclear factor-κB activation during lung inflammation: an in vivo imaging study

HMGB1 Facilitated Macrophage Reprogramming towards a Proinflammatory M1-like Phenotype in Experimental Autoimmune Myocarditis Development

Mechanisms regulating endothelial permeability

Pulmonary retention of primed neutrophils: a novel protective host response, which is impaired in the acute respiratory distress syndrome

SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes

role and therapeutic potential of circulating histones in acute inflammatory disorders

New Markers of Inflammation and Endothelial Cell Activation

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine

Differentiation of monocytes to macrophages primes cells for lipopolysaccharide stimulation via accumulation of cytoplasmic nuclear factor kappaB

Comparison of Hospitalized Patients With ARDS Caused by COVID-19 and H1N1

Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer

Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. The Lancet Infectious Diseases

Selective depletion of alveolar macrophages in polymicrobial sepsis increases lung injury, bacterial load and mortality but does not affect cytokine release

Impact of serum biomarkers and clinical factors on intensive care unit mortality and 6-month outcome in relatively healthy patients with severe pneumonia and acute respiratory distress syndrome

Contributions of high mobility group box protein in experimental and clinical acute lung injury

Pathophysiology of acute respiratory distress syndrome. Glucocorticoid receptor-mediated regulation of inflammation and response to prolonged glucocorticoid treatment

Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19. The New England journal of medicine

Endothelium--role in regulation of coagulation and inflammation

Circulating nucleosomes and neutrophil activation as risk factors for deep vein thrombosis. Arteriosclerosis, thrombosis, and vascular biology

HMGB1 release by inflammasomes

The pivotal link between ACE2 deficiency and SARS-CoV-2 infection

Nutrition, supplements, and vitamins in platelet function and bleeding

Priming and de-priming of neutrophil responses in vitro and in vivo

Defective Regulation of CXCR2 Facilitates Neutrophil Release from Bone Marrow Causing Spontaneous Inflammation in Severely NF-κB-Deficient Mice

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Necroptosis regulated proteins expression is an early prognostic biomarker in patient with sepsis: a prospective observational study

Aveolar Macrophage Activation and Cytokine Storm in the Pathogenesis of Severe COVID-19

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan

NF-κB p50 Regulates C/EBPα Expression and Inflammatory Cytokine-Induced Neutrophil Production

The laboratory tests and host immunity of COVID-19 patients with different severity of illness

Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin

Targeting HMGB1 in the treatment of sepsis

HMGB1 as a late mediator of lethal systemic inflammation

HMGB1 participates in LPS-induced acute lung injury by activating the AIM2 inflammasome in macrophages and inducing polarization of M1 macrophages via TLR2, TLR4, and RAGE/NF-κB signaling pathways

Effects of aspirin on the expression of nuclear factor-κB in a rat model of acute pulmonary embolism

Neutrophil Necroptosis Is Triggered by Ligation of Adhesion Molecules following GM-CSF Priming

Leukocyte integrin Mac-1 regulates thrombosis via interaction with platelet GPIbα

Mitochondrial ROS promote macrophage pyroptosis by inducing GSDMD oxidation

Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures

Immune Cell Profiling of COVID-19 Patients in the Recovery Stage by Single-Cell Sequencing

Genome-level expression profiles in pediatric septic shock indicate a role for altered zinc homeostasis in poor outcome

Insights into the immuno-pathogenesis of acute respiratory distress syndrome

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Inhibition of Alveolar Macrophage Pyroptosis Reduces Lipopolysaccharide-induced Acute Lung Injury in Mice

Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19

N-acetylcysteine reduces oxidative stress, nuclear factor-κB activity and cardiomyocyte apoptosis in heart failure

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention

COVID-19 -what should anaethesiologists and intensivists know about it? Anaesthesiology intensive therapy

Macrophage endocytosis of high-mobility group box 1 triggers pyroptosis

Sepsis and ARDS: The Dark Side of Histones

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Diagnostic and prognostic utility of tissue factor for severe sepsis and sepsis-induced acute lung injury

Platelets in the pathogenesis of acute respiratory distress syndrome. American journal of physiology Lung cellular and molecular physiology

Use of plasma mitochondrial DNA levels for determining disease severity and prognosis in pediatric sepsis: a case control study

The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients

New Insights into the Immune Molecular Regulation of the Pathogenesis of Acute Respiratory Distress Syndrome

The cytokine activity of HMGB1

Hemorrhagic shock primes for lung vascular endothelial cell pyroptosis: role in pulmonary inflammation following LPS

Cell Pyroptosis, a Potential Pathogenic Mechanism of 2019-nCoV Infection

Pathological evidence for residual SARS-CoV-2 in pulmonary tissues of a ready-for-discharge patient

Neutrophil priming occurs in a sequential manner and can be visualized in living animals by monitoring IL-1β promoter activation

Macrophage Polarization in Physiological and Pathological Pregnancy

Endothelial cell control of thrombosis

The pathogenesis and treatment of the `Cytokine Storm' in COVID-19. The Journal of infection

Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps

What drives neutrophils to the alveoli in ARDS?

The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality

COVID-19 infection induces readily detectable morphological and inflammation-related phenotypic changes in peripheral blood monocytes, the severity of which correlate with patient outcome

Circulating histones: a novel target in acute respiratory distress syndrome?

COVID-19: Melatonin as a potential adjuvant treatment

Dying as a Pathway to Death in Sepsis

Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients

Functional exhaustion of antiviral lymphocytes in COVID-19 patients

Necroptosis promotes cell-autonomous activation of proinflammatory cytokine gene expression

A Novel Coronavirus from Patients with Pneumonia in China

High mobility group box 1 protein as a potential drug target for infection-and injury-elicited inflammation

SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients

Platelet-Neutrophil Interplay: Insights Into Neutrophil Extracellular Trap (NET)-Driven Coagulation in Infection

Neutrophil extracellular traps in COVID-19. JCI Insight